# Marker Driven Selection of Patients for Prostate Biopsy and Management

> **NCT04240327** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Miami** · enrollment: 289 (actual)

## Conditions studied

- PSA
- Elevated PSA
- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04240327
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-06-29
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 289 (ACTUAL)
- **Last updated:** 2025-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04240327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04240327, "Marker Driven Selection of Patients for Prostate Biopsy and Management". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04240327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*